New Horizons in CAR-T Cell Therapy: Discover Our Latest Publication!
We are thrilled to announce the publication of a scientific paper titled: “From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy” authored byE. Pinto, L. Lione, M. Compagnone, M. Paccagnella, E. Salvatori, M. Greco, V. Frezza, E. Marra, L. Aurisicchio, G. Roscilli & A. Conforti. Our […]
The Visit of the Scientific Council of Rome Technopole
On January 27th, we were honored to host the General Director and the European Project Design Services team from Rome Technopole, the regional innovation ecosystem, at our headquarters. As co-leaders of Flagship Project 7, Takis plays a pivotal role in driving the development of advanced laboratories for diagnostic and therapeutic biopharmaceutical solutions. This project is […]
2024 was a transformative year for Takis!
A standout was the opening of our new BSL-3 Facility, boosting our research capabilities. We’ve also made significant strides in monoclonal antibody production, with scaling techniques showcased at key venues like I4ID2024 in Lyon. Takis was also selected for the IPCEI “Med4Cure” project, focusing on vaccines and gene therapies, including developing treatments for COVID-19 and […]
As Christmas approaches, we gathered to have a little celebration and enjoy some time all together.
Research doesn’t just happen in a lab. It is the result of effective teamwork.That’s why moments like this are so important! May this holiday season bring joy, warmth and inspiration to you and your families. Happy Holidays from all of us at Takis!
The Visit of a Delegation from Regione Lazio’s Economic Development Council
Yesterday we had the pleasure to welcome to our facilities a delegation from Regione Lazio‘s Economic Development Council, led by the Ass. Roberta Angelilli, and by the BoD of the Tecnopolo Roma. During the visit, our guests had the opportunity to explore Takis’ state-of-the-art infrastructure, including our newly inaugurated BSL-3 lab, a key asset for […]
We are pleased to announce the official inauguration of the first biosafety level 3 laboratory module (BSL3) in Italy
We are pleased to announce the official inauguration of the first biosafety level 3 laboratory module (#BSL3) in #Italy! This is not only a significant achievement but also a starting point for the future of the #biotech sector. The module, which is already operational, allows for the study of pathogens such as SARS-CoV-2, Dengue, Zika, […]
Science needs to run fast, so do we!
As our CEO said: “Science needs to run fast, so do we!” On the occasion of the hashtag#WC2024, Takis organized the “Takis Race” on September 19th, the final day of the conference, under the motto “Run like a scientist.” It was an initiative to support the scientific hashtag#research and bring together experts of the field, […]
What’s better than an “aperitivo” on the beach to celebrate the start of the summer holidays?
At Takis, we will continue to be open during August, delivering our services without interruption. However, we know that in Italy many take their holidays during August, including members of our staff of course, so we wanted to spend a moment together to wish everyone good holidays. It was a great opportunity to thank our […]
Takis at the RomeTechnopole Spoke 6 – International Young Researcher Workshop!
This workshop was held last week at Sapienza Università di Roma and our team, led by our CTO Giuseppe Roscilli, was there to share some of our cutting-edge hashtag#research projects. Valerio Chiarini, Ph.D. presented on “MATCH: An in-silico drive-through for mAbs discovery”. This innovative project utilizes ENEA’s High Performance Computing (HPC) resources to integrate in […]
On July 8th, Federica Signoretti and Matthew Golden from the U.S. Embassy came to Takis to learn about our company, our history, and the programs we are developing.
It was a pleasure to welcome the #embassy representatives and share with them our progress and #innovations in #research and #biotechnology. We had the opportunity to discuss our current initiatives and future projects including #cancer therapies and #immunization technologies. We thank the U.S. Embassy for their pleasant visit and interest in our company. Their presence […]